iRadimed Corporation Common Stock (IRMD)
Stock · NASDAQ · Health Care
$88.42as of 10/16/2026
Price chart
Active signals
IRMD Signal Track Record
How signals performed across all stocks →What IRMD's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 36 | +2.3% | 58% | September 18, 2026 |
| Bollinger Band Breakout | 28 | -1.0% | 46% | July 1, 2026 |
| 200-Day Moving Average TouchActive now | 20 | +1.9% | 55% | August 4, 2026 |
| Bollinger Band Breakdown | 19 | +4.6% | 58% | September 4, 2026 |
| Any 20-session window (baseline) | +1.9% | 60% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About IRMD
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 36…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 166
- Website
- www.iradimed.com/
Fundamentals
- 1-day range
- $89.13$91.05
- Market cap
- $1.17B
- P/E (trailing)
- 49.82
- P/E (forward)
- 36.43
- EPS (trailing)
- $1.79
- Dividend yield
- 0.91%
- Beta
- 0.94
- Avg. volume
- 123.0K
- Ex-dividend date
- August 14, 2026
- Dividend pay date
- August 28, 2026
How iRadimed Corporation Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 6, 2026 · via SEC EDGAR / Finnhub
Forecasts
2 analyst ratings
iRadimed Corporation Common Stock Competitors
Chosen by industry and closest market cap.
- IRMDiRadimed Corporation Common Stock$88.27▼ 1.23%Market cap $1.17BP/E 49.82$71.34$107.9
- BVSBioventus Inc. Class A Common Stock$13.3▼ 3.69%Market cap $1.17BP/E 21.32$6.46$15.89
- DRTSAlpha Tau Medical Ltd. Ordinary Shares$12.29▼ 6.61%Market cap $1.14BP/E —$3.43$15.79
- PRCTPROCEPT BioRobotics Corporation Common Stock$17.57▼ 3.20%Market cap $1.14BP/E —$16.67$38.11
- TNDMTandem Diabetes Care Inc. Common Stock$16.24▼ 1.69%Market cap $1.29BP/E —$12.26$29.65
- AORTArtivion Inc. Common Stock$21.78▼ 0.41%Market cap $1.29BP/E 117.64$19.16$48.25
- IARTIntegra LifeSciences Holdings Corporation Common Stock$13.21▼ 2.37%Market cap $1.33BP/E —$8.7$20.49
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| IRMD iRadimed Corporation Common Stock | $1.17B | 49.82 | $88.27 | ▼ 1.23% | $71.34$107.9 |
| BVS Bioventus Inc. Class A Common Stock | $1.17B | 21.32 | $13.3 | ▼ 3.69% | $6.46$15.89 |
| DRTS Alpha Tau Medical Ltd. Ordinary Shares | $1.14B | — | $12.29 | ▼ 6.61% | $3.43$15.79 |
| PRCT PROCEPT BioRobotics Corporation Common Stock | $1.14B | — | $17.57 | ▼ 3.20% | $16.67$38.11 |
| TNDM Tandem Diabetes Care Inc. Common Stock | $1.29B | — | $16.24 | ▼ 1.69% | $12.26$29.65 |
| AORT Artivion Inc. Common Stock | $1.29B | 117.64 | $21.78 | ▼ 0.41% | $19.16$48.25 |
| IART Integra LifeSciences Holdings Corporation Common Stock | $1.33B | — | $13.21 | ▼ 2.37% | $8.7$20.49 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →- KIANI JOE E · September 23, 2026 · Option Exercise698
- Monty K. Allen · September 3, 2026 · Sale405 @ $86.35
- Monty K. Allen · September 3, 2026 · Sale1.0K @ $86.44
- John Glenn · June 20, 2026 · Option Exercise5.8K
- John Glenn · June 20, 2026 · Tax Withholding2.3K @ $92.2
- Hilda Frederique Scharen-Guivel · June 4, 2026 · Sale1.2K @ $95
- Hilda Frederique Scharen-Guivel · June 4, 2026 · Sale1.8K @ $95
- Roger E. Susi · June 1, 2026 · Sale775 @ $89.79
- Roger E. Susi · June 1, 2026 · Sale924 @ $91.91
- Roger E. Susi · June 1, 2026 · Sale401 @ $91.08
- Roger E. Susi · June 1, 2026 · Sale400 @ $88.68
- Roger E. Susi · May 27, 2026 · Sale333 @ $92.61
- Roger E. Susi · May 27, 2026 · Sale2.2K @ $91.85
- Roger E. Susi · May 26, 2026 · Sale1.9K @ $92.93
- Roger E. Susi · May 26, 2026 · Sale3.1K @ $91.81
Institutional Ownership
March 31, 2026
- Total shares held
- 7.43M
- Total value held
- $650.48M
- Institutional holders
- 217
- Unknown967.8K
- Unknown440.7K
- Unknown359.3K
- Unknown358.6K
- Unknown349.3K
- Unknown334.5K
- Unknown286.6K
- Unknown256.7K
- Unknown226.1K
- Unknown204.5K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
iRadimed Gets Needham Hold Rating and Conference Participation
Needham initiated coverage on iRadimed with a Hold rating, while the company announced it will speak at the ROTH Healthcare Opportunities Conference. These developments add analyst visibility to the stock, which is currently trading near its 52-week high. The new coverage provides a fresh perspective on the company's position in the medical imaging sector.
iRadimed Gets Needham Hold Rating and Conference Participation. Needham initiated coverage on iRadimed with a Hold rating, while the company announced it will speak at the ROTH Healthcare Opportunities Conference. These developments add analyst visibility to the stock, which is currently trading near its 52-week high. The new coverage provides a fresh perspective on the company's position in the medical imaging sector.